Can a walking program ease chronic pain? new study tests feasibility

NCT ID NCT05700383

Completed Symptom relief Sponsor: Massachusetts General Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a 10-week mind-body walking program (GetActive-Fitbit) is feasible for adults with chronic musculoskeletal pain. 92 participants were randomly assigned to either the walking program or a health education group. The goal was to see if people would join, stick with it, and find it helpful, paving the way for a larger trial.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: GetActive-Fitbit program (behavioral intervention: mind-body skills, walking, and cognitive techniques)
What this could lead to: If successful, this could lead to a larger trial that may confirm a low-cost, non-drug program to help people with chronic pain move better and feel better.
What could go wrong: This is a small feasibility study (92 participants) testing only whether the program can be delivered and accepted, not whether it works. Results may not apply to all pain types or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC PAIN

Contacts and locations

Locations

Duke University

Durham, North Carolina, 27705, United States
Massachusetts General Hospital

Boston, Massachusetts, 02114, United States
Rush Medical Center

Chicago, Illinois, 60612, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.